Target intelligence / Profile preview

Ubiquitin thioesterase OTUB1 (OTUB1)

Target
OTUB1
Molecular classification
Enzyme, Deubiquitinating enzyme (DUB), Cysteine protease
01

Overview

Ubiquitin thioesterase OTUB1 is a human deubiquitinating enzyme (DUB) belonging to the OTU (ovarian tumor) superfamily of cysteine proteases[1][3][7]. It preferentially cleaves Lys48-linked polyubiquitin chains, regulating ubiquitin-dependent protein degradation and other signaling pathways such as the DNA damage response. OTUB1 functions by direct substrate deubiquitination and by a unique non-catalytic mechanism where it inhibits the E2 ubiquitin-conjugating enzyme UBC13, thereby suppressing Lys63-linked polyubiquitination involved in DNA repair[2]. OTUB1 participates in various multi-protein complexes, influencing processes such as RNA processing and cell adhesion[3]. Dysregulation of OTUB1 has been linked to cancer and abnormal immune responses. While no approved drugs currently target OTUB1, engineered ubiquitin variants selectively modulate its enzymatic activity in experimental settings[5].

Other names
Otubain-1OTU domain-containing ubiquitin aldehyde-binding protein 1OTUB1_HUMAN[4][6][7]
02

Mechanism of action

Inhibition of deubiquitinase activity; Modulation of Lys48-linked polyubiquitin chain cleavage; Non-canonical inhibition of E2 ubiquitin-conjugating enzymes (specifically UBC13)

03

Biological functions

Protein deubiquitinationRegulation of ubiquitin-mediated proteolysisDNA damage responseImmune responseRegulation of cell cycle and apoptosis[2][3][7]RNA processing
04

Disease associations

Cancer[3]InflammationDNA repair disordersNeurodegenerative disease (suggested but not definitively proven in results)
05

Safety considerations

Notable therapeutic challenges include the specificity of inhibition due to the overlap of substrate and partner binding domains, and potential for broad impact across ubiquitin-mediated cellular pathways[5]

Beyond the preview

Go deeper on Ubiquitin thioesterase OTUB1 (OTUB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin thioesterase OTUB1 (OTUB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call